$880 Million is the total value of Rhenman & Partners Asset Management AB's 86 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANNX | Exit | ANNEXON INC | $0 | – | -250,000 | -100.0% | -0.07% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.09% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.21% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -287,081 | -100.0% | -0.25% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -15,000 | -100.0% | -0.31% | – |
| ACCD | Exit | ACCOLADE INC | $0 | – | -200,000 | -100.0% | -0.35% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -150,000 | -100.0% | -0.40% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -235,000 | -100.0% | -0.45% | – |
| RCM | Exit | R1 RCM INC | $0 | – | -282,189 | -100.0% | -0.74% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -187,000 | -100.0% | -1.55% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -136,000 | -100.0% | -1.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.